Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.

There was a trend for reduction in coronary restenosis and lower extremity revascularization in the adjunctive cilostazol group versus the clopidogrel monotherapy group; however, it did not reach statistical significance (Table 2 ).

also in 111,027 other papers